ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

TBPH Theravance Biopharma Inc

9.29
-0.31 (-3.23%)
May 17 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 13.2M11.05M12.45M14.65M10.42M13.75M15.69M17.57M
Operating Income -13.39M1.25M-9.15M-17.43M-24.91M-16.12M-8.76M-6.24M
Pre Tax Income -25.42M-8.2M-44.94M-14.26M-22.48M-14.19M-7.58M-5.02M
Net Income -25.95M-8.19M916.63M-10.36M-22.09M-15.65M-8.95M-8.51M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -13.77M1.25M-9.15M-17.43M-24.91M-16.12M-8.76M-6.24M
EBITDA -12.25M2.51M-8.49M-17.89M-24.29M-15.57M-8.33M-5.95M
Year End December 30 2023 20162017201820192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 48.65M15.39M60.37M73.41M71.86M55.31M51.35M57.42M
Operating Income -180.47M-260.12M-227.57M-218.21M-229.32M-153.8M-91.96M-56.04M
Pre Tax Income -180.56M-271.71M-226.09M-241.68M-286.54M-199.58M-92.82M-49.27M
Net Income -190.67M-285.41M-215.52M-236.46M-278.02M-199.43M872.13M-55.19M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) -3.609-5.248-3.871-4.147-4.322-2.67913.371-1.108
EBIT -180.47M-260.12M-227.57M-218.21M-244.78M-153.8M-91.96M-56.04M
EBITDA -178.27M-257.62M-224.57M-214.91M-226.02M-150.3M-89.36M-54.14M